The role of self-monitoring of blood glucose in patients treated with SGLT-2 inhibitors: A European expert recommendation

Schnell O., Alawi H., Battelino T., Ceriello A., Diem P., Felton A., ...Daha Fazla

Journal of Diabetes Science and Technology, cilt.8, sa.4, ss.783-790, 2014 (Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8 Sayı: 4
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1177/1932296814534366
  • Dergi Adı: Journal of Diabetes Science and Technology
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.783-790
  • Anahtar Kelimeler: Hypoglycemia, Self-monitoring of blood glucose, SGLT-2 inhibitors, SMBG, Type 2 diabetes
  • İstanbul Üniversitesi Adresli: Evet

Özet

The role for the novel treatment approach of sodium-glucose cotransporter-2 (SGLT-2) in type 2 diabetes is increasing. Structured self-monitoring of blood glucose (SMBG), based on a less intensive and a more intensive scheme, may contribute to an optimization of SGLT-2 inhibitor based treatment. The current expert recommendation suggests individualized approaches of SMBG, using simple and clinically applicable schemes. Potential benefits of SMBG in SGLT-2 inhibitor based treatment approaches are early assessment of treatment success or failure, timely modification of treatment, detection of hypoglycemic episodes, assessment of glucose excursions, and support of diabetes management and education. The length and frequency of SMBG should depend on the clinical setting and the quality of metabolic control. © 2014 Diabetes Technology Society.